Genetic Mutations Linked to Drug Resistance in Pediatric Epilepsy
Researchers studied the relationship between specific genetic variations in the SCN1A gene and resistance to sodium valproate, a common epilepsy medication, in children.
Pediatric epilepsy research translated for parents into normal language, including summaries about diagnosis, treatments, school, safety, and safety.
Researchers studied the relationship between specific genetic variations in the SCN1A gene and resistance to sodium valproate, a common epilepsy medication, in children.
Researchers studied how cognitive function is affected in children with epilepsy, particularly those who might need surgery.
Researchers conducted a study to explore the use of a secure digital tool for sharing videos of suspected seizures in children.
Researchers conducted a study to understand how effective first-line antiseizure medications (ASMs) are for children newly diagnosed with epilepsy.
Researchers conducted a study to examine the experiences and outcomes of pregnant individuals with epilepsy.
Researchers investigated the use of intravenous (i/v) levetiracetam (LEV) as a first-line treatment for patients experiencing non-convulsive status epilepticus (NCSE), a serious condition where seizures occur without noticeable convulsions.
Researchers conducted a study to compare the effectiveness and safety of two medications, levetiracetam and sodium valproate, in treating children aged 1 to 16 years who were experiencing refractory generalized convulsive status epilepticus.
Researchers at Yangon Children’s Hospital studied the effectiveness of two medications, levetiracetam and phenobarbital, for treating prolonged seizures in children who did not respond to benzodiazepines.
Researchers conducted a study to analyze trends in pediatric epilepsy treatment research from 2005 to 2025.